A Randomized, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 Mcg Once Daily Versus Fluticasone Propionate 250 Mcg Twice Daily in Asthmatic Adolescent and Adult Subjects With Exercise-Induced Bronchoconstriction.

Trial Profile

A Randomized, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 Mcg Once Daily Versus Fluticasone Propionate 250 Mcg Twice Daily in Asthmatic Adolescent and Adult Subjects With Exercise-Induced Bronchoconstriction.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 08 Aug 2014

At a glance

  • Drugs Vilanterol/fluticasone furoate (Primary) ; Fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 29 Sep 2011 Planned initiation date changed from 30 Sep 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov
    • 21 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top